Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Apr 30, 2025 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -20.10%27.51B | 7.77%34.43B | 25.96%9.12B | 11.44%9.01B | 4.90%8.76B | -8.83%7.54B | -9.67%31.95B | -18.76%7.24B | -8.35%8.08B | 8.35B |
| Cost of revenue | -21.83%25.1B | 15.07%32.11B | 26.22%8.55B | 23.06%8.57B | 11.88%7.92B | -0.25%7.06B | -9.78%27.9B | -16.96%6.77B | -9.46%6.97B | 7.08B |
| Gross profit | 3.90%2.42B | -42.56%2.33B | 22.18%575.18M | -61.22%432.21M | -34.01%838.64M | -59.79%479.14M | -8.94%4.05B | -38.06%470.77M | -0.77%1.11B | 1.27B |
| Operating expense | 2.73%1.56B | 5.18%1.51B | -15.58%304.89M | -0.42%362.24M | 27.01%448.77M | 10.23%398.66M | -3.52%1.44B | -18.74%361.18M | 1.47%363.76M | 353.34M |
| Staff costs | ---- | 7.28%679.73M | ---- | ---- | ---- | ---- | -1.73%633.58M | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | 10.47%388.51M | ---- | ---- | ---- | ---- | -22.75%351.69M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 21.21%177.79M | ---- | ---- | ---- | ---- | 36.03%146.69M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 2.78%210.71M | ---- | ---- | ---- | ---- | -40.99%205.01M | ---- | ---- | ---- |
| Depreciation and amortization | ---- | 22.18%51.12M | ---- | ---- | ---- | ---- | -13.56%41.84M | ---- | ---- | ---- |
| -Depreciation | ---- | 22.18%51.12M | ---- | ---- | ---- | ---- | -13.56%41.84M | ---- | ---- | ---- |
| Rent and land expenses | ---- | -0.60%86.1M | ---- | ---- | ---- | ---- | 3.18%86.61M | ---- | ---- | ---- |
| Other operating expenses | ---- | -5.25%309.1M | ---- | ---- | ---- | ---- | 25.39%326.22M | ---- | ---- | ---- |
| Operating profit | 6.09%859.97M | -68.92%810.61M | 146.65%270.29M | -90.68%69.97M | -57.51%389.87M | -90.30%80.47M | -11.68%2.61B | -65.27%109.59M | -1.81%750.65M | 917.56M |
| Net non-operating interest income (expenses) | -95.19%-24.73M | -246.34%-12.67M | -416.38%-6.97M | -171.23%-5M | -75.27%-645K | 37.37%-62K | 66.35%-3.66M | 67.41%-1.35M | 56.02%-1.84M | -368K |
| Non-operating interest income | 10,078.26%2.34M | -8.00%23K | 33.33%12K | 0.00%2K | -38.46%8K | 0.00%1K | 31.58%25K | -18.18%9K | 100.00%2K | --13K |
| Non-operating interest expense | 113.28%27.07M | 244.61%12.69M | 413.84%6.98M | 171.04%5M | 71.39%653K | -37.00%63K | -66.18%3.68M | -67.28%1.36M | -55.98%1.84M | --381K |
| Net investment income | 11.75%1.91M | 11.90%1.71M | 0 | 9.66%851K | 0 | 14.21%860K | 7.60%1.53M | 0 | 15.30%776K | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 817.81%73.62M | -97.92%-10.26M | 35.98%-5.18M | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 130.10%3.08M | -102.32%-10.24M | -10.24M | 0 | 0 | 0 | 138.67%441.25M | 0 | 0 | 0 |
| Less:Other special charges | 48.65%-3.08M | 98.64%-6M | ---- | ---- | ---- | ---- | -138.67%-441.25M | --0 | --0 | --0 |
| Less:Write off | ---- | --16.24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 94.77%-6.97M | -799.37%-133.26M | -3,903.98%-138.78M | 55.86%-335K | 86.29%-1.62M | 506.16%7.47M | 49.99%-14.82M | 87.34%-3.47M | 86.68%-759K | -11.83M |
| Income before tax | 40.41%906.88M | -78.66%645.89M | 4.48%104.05M | -91.25%65.49M | -57.19%387.61M | -93.03%88.75M | -2.06%3.03B | -78.86%99.58M | -0.86%748.82M | 905.37M |
| Income tax | -6.97%333.49M | -63.13%358.49M | 218.33%146.9M | -73.70%62.58M | -56.52%124.68M | -93.94%24.33M | -1.18%972.4M | -71.45%46.15M | 0.28%237.96M | 286.79M |
| Net income | 99.51%573.39M | -86.01%287.4M | -180.19%-42.85M | -99.43%2.91M | -57.50%262.92M | -92.61%64.41M | -2.47%2.05B | -82.73%53.44M | -1.38%510.87M | 618.58M |
| Net income continuous operations | 99.51%573.39M | -86.01%287.4M | -180.19%-42.85M | -99.43%2.91M | -57.50%262.92M | -92.61%64.41M | -2.47%2.05B | -82.73%53.44M | -1.38%510.87M | --618.58M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 99.51%573.39M | -86.01%287.4M | -180.19%-42.85M | -99.43%2.91M | -57.50%262.92M | -92.61%64.41M | -2.47%2.05B | -82.73%53.44M | -1.38%510.86M | 618.58M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 99.51%573.39M | -86.01%287.4M | -180.19%-42.85M | -99.43%2.91M | -57.50%262.92M | -92.61%64.41M | -2.47%2.05B | -82.73%53.44M | -1.38%510.86M | 618.58M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 99.52%111.33 | -86.01%55.8 | -180.15%-8.32 | -99.43%0.57 | -57.50%51.04 | -92.61%12.51 | -12.12%398.9 | -83.53%10.38 | -11.97%99.18 | 120.1 |
| Diluted earnings per share | 99.52%111.33 | -86.01%55.8 | -180.20%-8.32 | -99.43%0.5656 | -57.50%51.04 | -92.61%12.51 | -12.12%398.9 | -82.73%10.3745 | -2.78%99.18 | 120.0987 |
| Dividend per share | 0.00%120 | 0.00%120 | 0.00%60 | 0 | 0.00%60 | 0 | 20.00%120 | -40.00%60 | 0 | 60 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |